NCOA4 Polyclonal Antibody, RBITC Conjugated
Product Specifications
Background
Enhances the androgen receptor transcriptional activity in prostate cancer cells. Ligand-independent coactivator of the peroxisome proliferator-activated receptor (PPAR) gamma.
Synonyms
70 kDa androgen receptor activator; 70 kDa androgen receptor coactivator; 70 kDa AR activator; 70 kDa AR-activator; Androgen receptor coactivator 70 kD; Androgen receptor coactivator 70 kDa protein; Androgen receptor-associated protein of 70 kDa; ARA 70; ARA70; DKFZp762E1112; ELE 1; ELE1; ELE1/ret TK; NCOA 4; NCoA-4; NCOA4_HUMAN; Nuclear receptor coactivator 4; Papillary thyroid carcinoma 3; PTC 3; PTC3; RET activating gene ELE1; Ret activating protein ELE1; Ret-activating protein ELE1; RFG.
Gene ID
8031
Swiss Prot
Q13772
Cellular Locus
Nucleus
Host
Rabbit
Cross Reactivity
Human
Immunogen
1-100/614
Target
NCOA4
Clonality
Polyclonal
Isotype
IgG
Conjugation
RBITC
Source
KLH conjugated synthetic peptide derived from human NCOA4
Applications
IF
Purification
Purified by Protein A.
Excitation Emission
570nm/595nm
Concentration
1µg/µl
Dilution
IF ()
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
8031
Predicted Cross Reactivity
Mouse, Rat, Cow, Sheep, Pig, Horse
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2482204 1.0 µg DNA
TRNAE3 sgRNA CRISPR Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
